Imipenem-cilastatin induced pure white cell aplasia
| dc.contributor.author | Kalambokis, G. | en |
| dc.contributor.author | Vassou, A. | en |
| dc.contributor.author | Bourantas, K. | en |
| dc.contributor.author | Tsianos, E. V. | en |
| dc.date.accessioned | 2015-11-24T19:12:06Z | |
| dc.date.available | 2015-11-24T19:12:06Z | |
| dc.identifier.issn | 0036-5548 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/21018 | |
| dc.rights | Default Licence | - |
| dc.subject | Aged | en |
| dc.subject | Agranulocytosis/*chemically induced | en |
| dc.subject | Cilastatin/adverse effects | en |
| dc.subject | Drug Combinations | en |
| dc.subject | Female | en |
| dc.subject | Humans | en |
| dc.subject | Imipenem/adverse effects | en |
| dc.subject | Leukocyte Count | en |
| dc.title | Imipenem-cilastatin induced pure white cell aplasia | en |
| heal.abstract | Antibiotic-induced severe neutropenia and less frequently agranulocytosis has been reported. In most of these cases a relatively normal myelopoiesis is found. We report on the first case of agranulocytosis with histological evidence of pure white cell aplasia associated with imipenem-cilastatin treatment. | en |
| heal.access | campus | - |
| heal.fullTextAvailability | TRUE | - |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/16138439 | - |
| heal.identifier.secondary | http://informahealthcare.com/doi/abs/10.1080/00365540510040205 | - |
| heal.journalName | Scand J Infect Dis | en |
| heal.journalType | peer-reviewed | - |
| heal.language | en | - |
| heal.publicationDate | 2005 | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.type | journalArticle | - |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.type.en | Journal article | en |
Αρχεία
Φάκελος/Πακέτο αδειών
1 - 1 of 1
Φόρτωση...
- Ονομα:
- license.txt
- Μέγεθος:
- 1.74 KB
- Μορφότυπο:
- Item-specific license agreed upon to submission
- Περιγραφή: